IPCA Laboratories Ltd

Common Name
IPCA Laboratories
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
16,778
Ticker
IPCALAB
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Ipca Laboratories Ltd. is a prominent Indian pharmaceutical company that develops, manufactures, and markets a vast array of pharmaceutical products and active pharmaceutical ingredients (APIs). Estab...

IPCA Laboratories's GHG Emissions Data Preview

In 2025, IPCA Laboratories completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, IPCA Laboratories has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind IPCA Laboratories’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore IPCA Laboratories’s data sources below and access millions more through our Disclosure Search.

a. IPCA Laboratories's Annual Report 2025
a. IPCA Laboratories's Annual Report 2025
b. IPCA Laboratories's ESG Report 2024
b. IPCA Laboratories's ESG Report 2024
c. IPCA Laboratories's Annual Report 2023
c. IPCA Laboratories's Annual Report 2023

Insights into IPCA Laboratories's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of IPCA Laboratories amounted to 294,504 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of IPCA Laboratories decreased by 5.57%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

IPCA Laboratories's Scope 1 Emissions Over Time

2022202320242025045 k90 k135 k180 ktCO2e-18%+40%-3%
  • Total Scope 1
  • Year-over-Year Change

What are IPCA Laboratories's Scope 1 emissions?

In 2025, the total Scope 1 emissions of IPCA Laboratories were 169,992 metric tons of CO₂ equivalent (tCO₂e). a

Has IPCA Laboratories reduced its Scope 1 emissions over time?

Since 2022, IPCA Laboratories's Scope 1 emissions have increased by 11.94%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2024), IPCA Laboratories's Scope 1 emissions decreased by 2.6%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are IPCA Laboratories's Scope 2 emissions?

In 2025, IPCA Laboratories reported Scope 2 greenhouse gas (GHG) emissions of 124,512 tCO₂e without specifying the calculation method. a

Has IPCA Laboratories reduced its Scope 2 emissions over time?

Since 2022, IPCA Laboratories's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 28.73%, reflecting a declining long-term trend in Scope 2 emissions over time. a c

Compared to the previous year (2024), IPCA Laboratories's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that IPCA Laboratories 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does IPCA Laboratories use for Scope 2 reporting?

In 2025, IPCA Laboratories reported its Scope 2 emissions using an unspecified methodology. a

IPCA Laboratories's Scope 2 Emissions Over Time

2022202320242025045 k90 k135 k180 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into IPCA Laboratories's Value Chain Emissions

In 2025, IPCA Laboratories reported 287,887 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2025 disclosure of IPCA Laboratories includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

IPCA Laboratories's Scope 3 Emissions Over Time

20242025080 k160 k240 k320 ktCO2e-6%
  • Total Scope 3
  • Year-over-Year Change

What are IPCA Laboratories's Scope 3 emissions?

In 2025, IPCA Laboratories reported total Scope 3 emissions of 287,887 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2024), IPCA Laboratories's Scope 3 emissions remained relatively stable, indicating that IPCA Laboratories 's emissions have plateaued with no significant change in its value chain footprint. a

Insights into IPCA Laboratories’s GHG Emissions Intensity Compared to Industry Peers

In 2025, IPCA Laboratories reported Scope 1 greenhouse gas (GHG) emissions of 169,992 tCO₂e and total revenues of USD 1,036 millions. This translates into an emissions intensity of 164.03 tCO₂e per millions USD. a

IPCA Laboratories's Scope 1 Emissions Intensity Compared to Peers

1001,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OJDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$MAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$M

How does IPCA Laboratories's GHG emissions intensity compare to its peers?

In 2025, IPCA Laboratories reported a Scope 1 emissions intensity of 164.03 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does IPCA Laboratories rank on GHG emissions intensity within its industry?

In 2025, IPCA Laboratories ranked 20 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places IPCA Laboratories among the least efficient performers, with one of the highest emissions intensities in its sector. a

Insights into IPCA Laboratories's Total Carbon Footprint

In 2025, IPCA Laboratories reported a total carbon footprint of 582,391 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.84% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output. a

The largest contributor to IPCA Laboratories's total carbon footprint was Scope 3 emissions, accounting for 49.43% of the company's total carbon footprint, followed by Scope 1 emissions at 29.19%. a

Want Full Access to IPCA Laboratories's GHG Emissions Dataset?
Sign Up